Posts filtered by tags: TwoXAR[x]


 

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

A growing population of people with software experience plus an interest in life sciences is boosting drug development in the San Francisco Bay Area, according to panelists at an Xcelerating event.Innovation in the San Francisco Bay Area may first bring to mind tech behemoths like Facebook and Google. But some drug development companies in the region say its openness to new ideas and the combination of software experience and life sciences expertise are boosting their prospects.“For us inside t...
Tags: Google, Startups, Facebook, San Francisco, Trends, Tech, People, Innovation, Biotech, Life Sciences, Healthtech, San Francisco Bay Area, Daphne Koller, San Francisco blog main, SanFranciscoVC, TwoXAR


TwoXAR Lands $10M to Ramp Up AI-Based Drug Discovery Work

Drug discovery startup twoXAR has $10 million in funding to support its efforts to build a pipeline of drug candidates found by its proprietary artificial intelligence technology. SoftBank Ventures led the Series A round of financing, and was joined by the Andreessen Horowitz Bio Fund and OS Fund. Palo Alto, CA-based twoXAR has developed a drug discovery computing platform that it says is faster, less expensive, and more accurate than traditional laboratory approaches. The company claim...
Tags: Startups, San Francisco, Trends, Investing, Andreessen Horowitz, Biotech, Stanford University, Life Sciences, Palo Alto Ca, SoftBank Ventures, National blog main, New York blog main, San Francisco blog main, San Francisco top stories, Drug Discovery, RoboticsAI


Andreessen Horowitz Floats Second Bio Fund with $450M

Andreessen Horowitz, the storied Silicon Valley venture capital firm best known for backing technology companies such as Facebook and Airbnb, is more than doubling the commitment it first made in 2015 to bring engineering to bear on the mysteries of biology and disease. Encouraged by results from the $200 million Bio Fund it created two years ago, Andreessen today announced the formation of its second Bio Fund, which will have $450 million to invest in startups through growth-stage compan...
Tags: Deals, Startups, Facebook, Internet, Drugs, Entrepreneurship, Cancer, Funding, San Francisco, Trends, Web, It, Andreessen, Vc, Innovation, Venture Capital


Mayo Clinic and Boston Software Maker Add Qrativ to Busy A.I. Sector

This story is part of an ongoing series on A.I. in healthcare. Artificial intelligence systems have become a trendy, but useful means of extracting meaning out of the troves of scientific research and clinical data that institutions produce every year. Startups from San Francisco to Boston have launched with the goal of helping pharmaceutical companies decide what drugs to develop. Now, the nonprofit research group Mayo Clinic is entering the fray by launching a startup with Cambridge, MA...
Tags: Deals, Ge, Boston, San Francisco, Trends, Data, Artificial Intelligence, Software, Healthcare, Venture Capital, Cambridge, Machine Learning, Ibm Watson, Ibm, Software Development, Cancer Treatment